LexDanaLexDanabeta
Inventor

William Garth Rapeport

Inventor
London, GB

Overview

11→
Patents
2012–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 11 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07DHeterocyclic compounds39%
A61KPreparations for medical, dental or toiletry purposes21%
PatentTitleYear
10,144,721P38 MAP kinase inhibitors20189,260,410'P38 MAP kinase inhibitors'20169,242,960'P38MAP kinase inhibitors'20169,079,893'Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (RSV) infection'20158,975,285'P38 MAP kinase inhibitors'20158,642,773'P38MAP kinase inhibitor'20148,618,140'P38 MAP kinase inhibitors'20138,299,073'P38 MAP kinase inhibitors'20128,299,074'P38 MAP kinase inhibitors'20128,293,771'p38 MAP kinase inhibitors'20128,293,748'p38 MAP kinase inhibitors'2012

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2012–2018Patents assigned to RESPIVERT LTD (11)· patent assignee history
2012–2016Patents assigned to ITO KAZUHIRO (8)· patent assignee history
2012–2016Patents assigned to RAPEPORT WILLIAM GARTH (8)· patent assignee history
2012–2016Patents assigned to STRONG PETER (8)· patent assignee history
2012–2016Patents assigned to CHARRON CATHERINE ELISABETH (7)· patent assignee history
2012–2018Based in London, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RESPIVERT LTD112012–2018
ITO KAZUHIRO82012–2016
RAPEPORT WILLIAM GARTHself82012–2016
STRONG PETER82012–2016
CHARRON CATHERINE ELISABETH72012–2016
Locations
LocationPatentsSpan
London, GB112012–2018